Cargando…

A deep learning, image based approach for automated diagnosis for inflammatory skin diseases

BACKGROUND: As the booming of deep learning era, especially the advances in convolutional neural networks (CNNs), CNNs have been applied in medicine fields like radiology and pathology. However, the application of CNNs in dermatology, which is also based on images, is very limited. Inflammatory skin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Haijing, Yin, Heng, Chen, Haipeng, Sun, Moyuan, Liu, Xiaoqing, Yu, Yizhou, Tang, Yang, Long, Hai, Zhang, Bo, Zhang, Jing, Zhou, Ying, Li, Yaping, Zhang, Guiyuing, Zhang, Peng, Zhan, Yi, Liao, Jieyue, Luo, Shuaihantian, Xiao, Rong, Su, Yuwen, Zhao, Juanjuan, Wang, Fei, Zhang, Wei, Zhang, Jin, Lu, Qianjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290553/
https://www.ncbi.nlm.nih.gov/pubmed/32566608
http://dx.doi.org/10.21037/atm.2020.04.39
Descripción
Sumario:BACKGROUND: As the booming of deep learning era, especially the advances in convolutional neural networks (CNNs), CNNs have been applied in medicine fields like radiology and pathology. However, the application of CNNs in dermatology, which is also based on images, is very limited. Inflammatory skin diseases, such as psoriasis (Pso), eczema (Ecz), and atopic dermatitis (AD), are very easily to be mis-diagnosed in practice. METHODS: Based on the EfficientNet-b4 CNN algorithm, we developed an artificial intelligence dermatology diagnosis assistant (AIDDA) for Pso, Ecz & AD and healthy skins (HC). The proposed CNN model was trained based on 4,740 clinical images, and the performance was evaluated on experts-confirmed clinical images grouped into 3 different dermatologist-labelled diagnosis classifications (HC, Pso, Ecz & AD). RESULTS: The overall diagnosis accuracy of AIDDA is 95.80%±0.09%, with the sensitivity of 94.40%±0.12% and specificity 97.20%±0.06%. AIDDA showed accuracy for Pso is 89.46%, with sensitivity of 91.4% and specificity of 95.48%, and accuracy for AD & Ecz 92.57%, with sensitivity of 94.56% and specificity of 94.41%. CONCLUSIONS: AIDDA is thus already achieving an impact in the diagnosis of inflammatory skin diseases, highlighting how deep learning network tools can help advance clinical practice.